Lange JM - Search Results

1

Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA cohort.

Dieleman JP, Jambroes M, Gyssens IC, Sturkenboom MC, Stricker BH, Mulder WM, de Wolf F, Weverling GJ, Lange JM, Reiss P, Brinkman K; ATHENA Study Group. Dieleman JP, et al. Among authors: lange jm. AIDS. 2002 Mar 29;16(5):737-45. doi: 10.1097/00002030-200203290-00009. AIDS. 2002. PMID: 11964530

2

Therapeutic drug monitoring of nelfinavir and indinavir in treatment-naive HIV-1-infected individuals.

Burger D, Hugen P, Reiss P, Gyssens I, Schneider M, Kroon F, Schreij G, Brinkman K, Richter C, Prins J, Aarnoutse R, Lange J; ATHENA Cohort Study Group. Burger D, et al. AIDS. 2003 May 23;17(8):1157-65. doi: 10.1097/00002030-200305230-00007. AIDS. 2003. PMID: 12819517 Clinical Trial.

3

Improved long-term suppression of HIV-1 replication with a triple-class multidrug regimen compared with standard of care antiretroviral therapy.

van Praag RM, Wit FW, Jurriaans S, de Wolf F, Prins JM, Lange JM. van Praag RM, et al. Among authors: lange jm. AIDS. 2002 Mar 29;16(5):719-25. doi: 10.1097/00002030-200203290-00007. AIDS. 2002. PMID: 11964528

4

Low risk of treatment failure after substitution of nevirapine for protease inhibitors among human immunodeficiency virus-infected patients with virus suppression.

Dieleman JP, Sturkenboom MC, Wit FW, Jambroes M, Mulder JW, Ten Veen JH, Juttmann J, Stricker BH, Lange JM, Van Der Ende ME; AIDS Therapy Evaluation, The Netherlands Study Group (ATHENA). Dieleman JP, et al. Among authors: lange jm. J Infect Dis. 2002 May 1;185(9):1261-8. doi: 10.1086/340131. Epub 2002 Apr 16. J Infect Dis. 2002. PMID: 12001043

5

Mortality and progression to AIDS after starting highly active antiretroviral therapy.

van Sighem AI, van de Wiel MA, Ghani AC, Jambroes M, Reiss P, Gyssens IC, Brinkman K, Lange JM, de Wolf F; ATHENA Cohort Study Group. van Sighem AI, et al. Among authors: lange jm. AIDS. 2003 Oct 17;17(15):2227-36. doi: 10.1097/00002030-200310170-00011. AIDS. 2003. PMID: 14523280

6

Safety of long-term interruption of successful antiretroviral therapy: the ATHENA cohort study.

Wit FW, Blanckenberg DH, Brinkman K, Prins JM, van der Ende ME, Schneider MM, Mulder JW, de Wolf F, Lange JM; ATHENA Study Group. Wit FW, et al. Among authors: lange jm. AIDS. 2005 Feb 18;19(3):345-8. AIDS. 2005. PMID: 15718848

7

HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.

Steingrover R, Pogány K, Fernandez Garcia E, Jurriaans S, Brinkman K, Schuitemaker H, Miedema F, Lange JM, Prins JM. Steingrover R, et al. Among authors: lange jm. AIDS. 2008 Aug 20;22(13):1583-8. doi: 10.1097/QAD.0b013e328305bd77. AIDS. 2008. PMID: 18670217

8

Viral replication under combination antiretroviral therapy: a comparison of four different regimens.

Ghani AC, Ferguson NM, Fraser C, Donnelly CA, Danner S, Reiss P, Lange J, Goudsmit J, Anderson RM, De Wolf F. Ghani AC, et al. J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):167-76. doi: 10.1097/00042560-200206010-00005. J Acquir Immune Defic Syndr. 2002. PMID: 12045679 Free article. Clinical Trial.

9

Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in the Netherlands.

Nellen JF, Wit FW, De Wolf F, Jurriaans S, Lange JM, Prins JM. Nellen JF, et al. Among authors: lange jm. J Acquir Immune Defic Syndr. 2004 Aug 1;36(4):943-50. doi: 10.1097/00126334-200408010-00008. J Acquir Immune Defic Syndr. 2004. PMID: 15220701

10

A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.

van Leeuwen R, Katlama C, Murphy RL, Squires K, Gatell J, Horban A, Clotet B, Staszewski S, van Eeden A, Clumeck N, Moroni M, Pavia AT, Schmidt RE, Gonzalez-Lahoz J, Montaner J, Antunes F, Gulick R, Bánhegyi D, van der Valk M, Reiss P, van Weert L, van Leth F, Johnson VA, Sommadossi JP, Lange JM. van Leeuwen R, et al. Among authors: lange jm. AIDS. 2003 May 2;17(7):987-99. doi: 10.1097/00002030-200305020-00007. AIDS. 2003. PMID: 12700448 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

460 results

Search Page

Filters